Titre : Produits du tabac

Produits du tabac : Questions médicales fréquentes

Termes MeSH sélectionnés :

Partial Thromboplastin Time
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Produits du tabac : Questions médicales les plus fréquentes", "headline": "Produits du tabac : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Produits du tabac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Produits du tabac" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dispositifs pour fumer", "url": "https://questionsmedicales.fr/mesh/D000074602", "about": { "@type": "MedicalCondition", "name": "Dispositifs pour fumer", "code": { "@type": "MedicalCode", "code": "D000074602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tabac sans fumée", "alternateName": "Tobacco, Smokeless", "url": "https://questionsmedicales.fr/mesh/D014030", "about": { "@type": "MedicalCondition", "name": "Tabac sans fumée", "code": { "@type": "MedicalCode", "code": "D014030", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844.500" } } }, { "@type": "MedicalWebPage", "name": "Tabac pour pipe à eau", "alternateName": "Tobacco, Waterpipe", "url": "https://questionsmedicales.fr/mesh/D000073846", "about": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau", "code": { "@type": "MedicalCode", "code": "D000073846", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Produits du tabac", "alternateName": "Tobacco Products", "code": { "@type": "MedicalCode", "code": "D062789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Takahiro Tabuchi", "url": "https://questionsmedicales.fr/author/Takahiro%20Tabuchi", "affiliation": { "@type": "Organization", "name": "Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan." } }, { "@type": "Person", "name": "Jennifer B Unger", "url": "https://questionsmedicales.fr/author/Jennifer%20B%20Unger", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America." } }, { "@type": "Person", "name": "Pamela M Ling", "url": "https://questionsmedicales.fr/author/Pamela%20M%20Ling", "affiliation": { "@type": "Organization", "name": "Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California." } }, { "@type": "Person", "name": "Silvano Gallus", "url": "https://questionsmedicales.fr/author/Silvano%20Gallus", "affiliation": { "@type": "Organization", "name": "Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy." } }, { "@type": "Person", "name": "Jessica L Barrington-Trimis", "url": "https://questionsmedicales.fr/author/Jessica%20L%20Barrington-Trimis", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors.", "datePublished": "2022-11-03", "url": "https://questionsmedicales.fr/article/36326895", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00210-022-02312-5" } }, { "@type": "ScholarlyArticle", "name": "A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36476549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2169/internalmedicine.0782-22" } }, { "@type": "ScholarlyArticle", "name": "Higher D-dimer and activated partial thromboplastin time are poor prognostic factors in patients with peritoneal dialysis-related peritonitis.", "datePublished": "2023-06-25", "url": "https://questionsmedicales.fr/article/37357362", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1744-9987.14027" } }, { "@type": "ScholarlyArticle", "name": "Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37395184", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001235" } }, { "@type": "ScholarlyArticle", "name": "Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.", "datePublished": "2023-02-22", "url": "https://questionsmedicales.fr/article/36759323", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/phar.2776" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Dispositifs pour fumer", "item": "https://questionsmedicales.fr/mesh/D000074602" }, { "@type": "ListItem", "position": 5, "name": "Produits du tabac", "item": "https://questionsmedicales.fr/mesh/D062789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Produits du tabac - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Produits du tabac", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Produits du tabac", "description": "Comment diagnostiquer une dépendance au tabac ?\nQuels tests pour évaluer les effets du tabac ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Partial+Thromboplastin+Time&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Produits du tabac", "description": "Quels sont les symptômes d'une intoxication au tabac ?\nComment le tabac affecte-t-il la respiration ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Partial+Thromboplastin+Time&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Produits du tabac", "description": "Comment prévenir le tabagisme chez les jeunes ?\nLes lois anti-tabac sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Partial+Thromboplastin+Time&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Produits du tabac", "description": "Quels traitements existent pour arrêter de fumer ?\nLes thérapies comportementales sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Partial+Thromboplastin+Time&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Produits du tabac", "description": "Quelles sont les complications du tabagisme ?\nLe tabac augmente-t-il le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Partial+Thromboplastin+Time&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Produits du tabac", "description": "Quels sont les facteurs de risque du tabagisme ?\nLe stress influence-t-il la consommation de tabac ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Partial+Thromboplastin+Time&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dépendance au tabac ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage." } }, { "@type": "Question", "name": "Quels tests pour évaluer les effets du tabac ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication au tabac ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques." } }, { "@type": "Question", "name": "Comment le tabac affecte-t-il la respiration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir le tabagisme chez les jeunes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles." } }, { "@type": "Question", "name": "Les lois anti-tabac sont-elles efficaces ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition." } }, { "@type": "Question", "name": "Quels traitements existent pour arrêter de fumer ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale." } }, { "@type": "Question", "name": "Les thérapies comportementales sont-elles efficaces ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme." } }, { "@type": "Question", "name": "Quelles sont les complications du tabagisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques." } }, { "@type": "Question", "name": "Le tabac augmente-t-il le risque de cancer ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du tabagisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux." } }, { "@type": "Question", "name": "Le stress influence-t-il la consommation de tabac ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants." } } ] } ] }

Sources (10000 au total)

A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies.

A prolonged activated partial thromboplastin time (APTT) is observed in patients with severe fever with thrombocytopenia syndrome (SFTS) and is one of the risk factors for severe disease. The mechanis...

Higher D-dimer and activated partial thromboplastin time are poor prognostic factors in patients with peritoneal dialysis-related peritonitis.

Coagulation system dysfunction is associated with adverse outcomes of peritoneal dialysis (PD) and bacterial infection. We investigated the association between coagulation system and treatment failure... We collected records of patients aged ≥18 years with PDRP. PDRP episodes were divided into: shortened activated partial thromboplastin time (APTT) group and prolonged APTT group, low D-dimer (DD) grou... Thirty episodes of treatment failure were observed in 110 episodes of PDRP in our study. After adjusting for variables, prolonged APTT (OR = 1.166 [1.049-1.296], p = 0.004) or high level of DD (OR = 1... Prolonged baseline APTT or high level of DD increased the risk of treatment failure of PDRP....

Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study.

Limited data is available on factor XII deficiency in critically ill patients with prolonged activated partial thromboplastin time (aPTT). The association of factor XII deficiency with an increased ri...

Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.

Thromboelastography (TEG) offers a more dynamic assessment of hemostasis over activated partial thromboplastin time (aPTT). However, the clinical utility of TEG in monitoring bivalirudin during extrac... Multicenter, retrospective, cohort study conducted over a 2-year period.... Two academic university medical centers (Banner University Medical Center) in Phoenix and Tucson, AZ.... Adult patients requiring ECMO and bivalirudin therapy with ≥1 corresponding standard TEG and aPTT plasma samples drawn ≤4 h of each other were included. The primary endpoint was to determine the corre... A total of 104 patients consisting of 848 concurrent laboratory assessments of R time and aPTT were included. A moderate correlation between TEG R time and aPTT was demonstrated in the study populatio... Moderate correlation was found between TEG R time and aPTT associated with bivalirudin during ECMO in critically ill adults. Further research is warranted to address the optimal test to guide clinical...

Meta-analysis of haematocrit and activated partial thromboplastin time as risk factors for unplanned interruptions in patients undergoing continuous renal replacement therapy.

Although continuous renal replacement therapy (CRRT) is common, unplanned interruptions often limit its usefulness. Unplanned interruption refers to the forced interruption of blood purification treat... A systematic review and a meta-analysis were performed by searching the databases of China National Knowledge Infrastructure, Wanfang, VIP, China Biomedical Literature, Cochrane Library, PubMed, Web o... Nine studies involving 1165 participants were included. Haematocrit and APTT were independent risk factors for the unplanned interruption of CRRT. The higher the haematocrit level, the greater the ris... Haematocrit and APTT are the influencing factors on the incidence of unplanned interruptions in critical patients undergoing CRRT....

Predictive value of immunoglobulin G, activated partial thromboplastin time, platelet, and indirect bilirubin for delayed viral clearance in patients infected with the Omicron variant.

Omicron is the recently emerged highly transmissible severe acute respiratory syndrome coronavirus 2 variant that has caused a dramatic increase in coronavirus disease-2019 infection cases worldwide. ... Approximately 278 Omicron cases at the Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine were retrospectively analyzed between August 11 and August 31, 2022. Demographic an... Univariate logistic regression analyses showed that a prolonged viral clearance time was significantly associated with older age and lower immunoglobulin (Ig) G and platelet (PLT) levels. Using multin... These findings suggest that direct bilirubin, IgG, PLT, and APTT are significant risk factors for a longer viral shedding duration in patients infected with Omicron. Measuring levels of direct bilirub...